On September 18, 2023, William B. Stilley, a member of Adial Pharmaceuticals, Inc. Board of Directors (the ?Board?), notified the Company of his decision to resign, effective as such date, from his position as a member of the Board and any other executive positions with the Company and its subsidiaries.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.238 USD | -0.96% | -14.62% | -33.44% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.44% | 5.02M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- ADIL Stock
- News Adial Pharmaceuticals, Inc.
- Adial Pharmaceuticals, Inc. Announces Board Changes